Predictive Immune Biomarkers of COVID-19 Pathogenesis to Influence Therapeutic Management

NCT04668170 · clinicaltrials.gov ↗

COMPLETED

Status

304

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Blood collection on admission and longitudinally
BIOLOGICAL: Blood collection on their first consultation and 10 to 14 days later

Sponsor

University Hospital, Toulouse